Clinical course and end-of-life care in patients who have died after allogeneic stem cell transplantation

PURPOSE: Allogeneic stem cell transplantation may cure approximately 50% of patients, however, a significant part of the other half might benefit from a high-quality palliative care medicine at the end of life. Somatic, psychic and spiritual needs of these patients may differ from those of patients...

Descripción completa

Detalles Bibliográficos
Autores principales: Busemann, Christoph, Jülich, Andreas, Buchhold, Britta, Schmidt, Vanessa, Schneidewind, Laila, Pink, Daniel, Schmidt, Christian Andreas, Neumann, Thomas, Krüger, William H.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer Berlin Heidelberg 2017
Materias:
Original Article – Clinical Oncology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7101727/
https://www.ncbi.nlm.nih.gov/pubmed/28551769
http://dx.doi.org/10.1007/s00432-017-2446-y

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7101727/
https://www.ncbi.nlm.nih.gov/pubmed/28551769
http://dx.doi.org/10.1007/s00432-017-2446-y

Ejemplares similares